<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR><BR><BR>1  INDICATIONS AND USAGE<BR><BR><BR><BR><BR>Carvedilol is an alpha/beta-adrenergic blocking agent indicated for the treatment of:Left ventricular dysfunction following myocardial infarction in clinically stable patients (1.1)1.1)Hypertension (1.2)1.2)Left ventricular dysfunction following myocardial infarction in clinically stable patients (1.1)1.1)<BR><BR><BR><BR><BR><BR>1.1  Left Ventricular Dysfunction Following Myocardial Infarction<BR>Carvedilol is indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of ≤40% (with or without symptomatic heart failure) [see Clinical Studies (14.1)Clinical Studies (14.1)]. [see Clinical Studies (14.1)Clinical Studies (14.1)].<BR><BR><BR><BR><BR><BR><BR>1.2  Hypertension<BR>Carvedilol is indicated for the management of essential hypertension [see Clinical Studies (14.2)Clinical Studies (14.2)]. It can be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics [see Drug Interactions (7.2)Drug Interactions (7.2)]. [see Clinical Studies (14.2)Clinical Studies (14.2)]. It can be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics<BR><BR><BR><BR><BR></P></DIV></HTML>